3,6-Dibromopyridazide CAS 17973-86-3

The research history of this type of compound can be traced back to the late 19th century, when German chemist Heinrich Blau first synthesized the pyridazine nucleus through the condensation reaction of phenylhydrazine and dicarbonyl compounds in 1886.

In 1886, Blau first reported a method for preparing pyridazine through the condensation reaction of phenylhydrazine and glyoxal, which was later known as "Blau" Synthesis method ". However, there was still controversy over the understanding of the product structure at the time, and it was not until 1901 that Arthur Hantzsch confirmed the molecular structure of pyridazine through systematic degradation experiments and elemental analysis. Early research faced two major challenges: low synthesis yield (usually<30%) and lack of effective structural characterization methods, which limited the in-depth study of pyridazine derivatives.

However, due to limitations in early organic chemistry theories and technological methods, systematic research on pyridine derivatives did not truly begin until the mid-20th century. In the development of heterocyclic chemistry, halogenated pyridines have gradually attracted attention due to their unique reactivity and structural characteristics. Among them, 3,6-dibromopyridazine, as a representative of symmetric dihalogenated derivatives, has become an important synthetic block for constructing complex heterocyclic systems due to its high reactivity in nucleophilic substitution reactions and excellent performance in metal catalyzed coupling reactions. The discovery and optimization process of this compound not only reflects the progress of organic synthesis methodology, but also demonstrates an important paradigm for the transformation of basic research into application fields.

The late 19th and early 20th centuries were the foundational period of organic heterocyclic chemistry.

In the 1930s, with the development of organic halogenation reaction theory, researchers began to attempt direct halogenation of pyridazine ring systems. In 1935, the British chemist Robert Robinson's team first reported the halogenation reaction of pyridazine under bromine water and successfully obtained monobrominated products. However, due to the high electron defect characteristics of pyridazine ring, direct bromination was limited. Often leads to the generation of multiple halogenated by-products, and the regioselectivity is difficult to control.

In 1948, Hans Meerwein from the Max Planck Institute in Germany developed a novel halogenation strategy - using N-bromosuccinimide (NBS) as the bromine source to achieve directional bromination of pyridine under specific solvent conditions. This method laid an important foundation for the subsequent discovery of 3,6-dibromopyridazine.

1953 marked an important turning point in the research of 3,6-Dibromopyridazide. Professor Charles D. Hurd's team from the University of Illinois has published a key paper in the Journal of the American Chemical Society, reporting the first highly selective synthesis of 3,6-dibromopyridazine through the reaction of pyridazine-N-oxide with phosphorus tribromide. This method has the following advantages: regional selectivity>95%
The reaction yield reaches 65-70%, and the product is easy to crystallize and purify. The study of reaction mechanism shows that N-oxide first forms an active intermediate with PBr ∝, then undergoes electrophilic bromination, and finally obtains the target product through elimination reaction. This discovery solves the problem of poor selectivity in direct bromination methods.

In the 1960s, with the development of modern analytical techniques, the structure of the compound was accurately characterized

In 1962, its crystal structure was first determined by X-ray single crystal diffraction (Cambridge Crystallographic Database entry number: PYRDAZ01)

1965: Nuclear magnetic resonance technology (¹ H NMR) was applied to analyze the compound, confirming its symmetrical structure

In 1968, mass spectrometry studies revealed its characteristic fragmentation mode (molecular ion peaks with m/z=236/238/240)